The impact of implanting cardioverter-defibrillators in patients who meet the multicenter automatic defibrillator implantation trial-II criteria on the health care system at a tertiary referral center
Sana M. Al‐Khatib(American Heart Association), Robert M. Califf(Duke University), James G. Jollis(Duke University), Linda K. Shaw(UCLA Health), Kerry Lee(National Institute of Education), Yun Li, Kevin Anstrom(PragmatIC (United Kingdom)), Christopher M. O’Connor(Inova Health System), Eric Peterson
Cited by 0
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Mayo Clinic Proceedings
|Mayo Clinic Proceedings|2000|2.2k
Depression, Heart Rate Variability, and Acute Myocardial Infarction
|Circulation|2001|763
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials
|Circulation|2018|712